Literature DB >> 17502287

Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer.

Jacqueline Clavel1.   

Abstract

Cancer epidemiology has undergone marked development since the 1950s. One of the most spectacular and specific contributions was the demonstration of the massive effect of smoking on the occurrence of lung, larynx, and bladder cancer. Major chemical, physical, and biological carcinogenic agents have been identified in the working environment and in the overall environment. The chain of events from environmental exposures to cancer requires hundreds of polymorphic genes coding for proteins involved in the transport and metabolism of xenobiotics, or in repair, or in an immune or inflammatory response. The multifactorial and multistage characteristics of cancer create the theoretical conditions for statistical interactions that have been exceptionally detected. Over the last two decades, a considerable mass of data has been generated, mostly addressing the interactions between smoking and xenobiotic-metabolizing enzymes in smoking-related cancers. They were sometimes considered disappointing, but they actually brought a lot of information and raised many methodological issues. In parallel, the number of polymorphisms that can be considered candidate per function increased so much that multiple testing has become a major issue, and genome wide-screening approaches have more and more gained in interest. Facing the resulting complexity, some instruments are being set up: our studies are now equipped with carefully sampled biological collections, high-throughput genotyping systems are becoming available, work on statistical methodologies is ongoing, bioinformatics databases are growing larger and access to them is becoming simpler; international consortiums are being organized. The roles of environmental and genetic factors are being jointly elucidated. The basic rules of epidemiology, which are demanding with respect to sampling, with respect to the histological and molecular criteria for cancer classification, with respect to the evaluation of environmental exposures, their timeframes, quantification and covariables, with respect to study size and with respect to the rigor of multivariate analyses, are more pertinent than ever before.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502287      PMCID: PMC1971138          DOI: 10.1016/j.crvi.2007.02.012

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  21 in total

1.  Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.

Authors:  P Vineis; D Marinelli; H Autrup; J Brockmoller; I Cascorbi; A K Daly; K Golka; H Okkels; A Risch; N Rothman; E Sim; E Taioli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

Review 2.  Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.

Authors:  Lawrence S Engel; Emanuela Taioli; Ruth Pfeiffer; Montserrat Garcia-Closas; Pamela M Marcus; Qing Lan; Paolo Boffetta; Paolo Vineis; Herman Autrup; Douglas A Bell; Robert A Branch; Jürgen Brockmöller; Ann K Daly; Susan R Heckbert; Ivan Kalina; Daehee Kang; Takahiko Katoh; Amalia Lafuente; Henry J Lin; Marjorie Romkes; Jack A Taylor; Nathaniel Rothman
Journal:  Am J Epidemiol       Date:  2002-07-15       Impact factor: 4.897

Review 3.  Genetics of melanoma predisposition.

Authors:  Nicholas K Hayward
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

4.  Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States).

Authors:  Loïc Le Marchand; Chuanfa Guo; Simone Benhamou; Christine Bouchardy; Ingolf Cascorbi; Margie L Clapper; Seymour Garte; Aage Haugen; Magnus Ingelman-Sundberg; Masahiro Kihara; Agneta Rannug; David Ryberg; Isabelle Stücker; Haruhiko Sugimura; Emanuela Taioli
Journal:  Cancer Causes Control       Date:  2003-05       Impact factor: 2.506

5.  Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk.

Authors:  Simone Benhamou; Won Jin Lee; Anna-Karin Alexandrie; Paolo Boffetta; Christine Bouchardy; Dorota Butkiewicz; Jurgen Brockmöller; Margie L Clapper; Ann Daly; Vita Dolzan; Jean Ford; Laura Gaspari; Aage Haugen; Ari Hirvonen; Kirsti Husgafvel-Pursiainen; Magnus Ingelman-Sundberg; Ivan Kalina; Masahiro Kihara; Pierre Kremers; Loïc Le Marchand; Stephanie J London; Valle Nazar-Stewart; Masako Onon-Kihara; Agneta Rannug; Marjorie Romkes; David Ryberg; Janeric Seidegard; Peter Shields; Richard C Strange; Isabelle Stücker; Jordi To-Figueras; Paul Brennan; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2002-08       Impact factor: 4.944

6.  Metabolic gene polymorphism frequencies in control populations.

Authors:  S Garte; L Gaspari; A K Alexandrie; C Ambrosone; H Autrup; J L Autrup; H Baranova; L Bathum; S Benhamou; P Boffetta; C Bouchardy; K Breskvar; J Brockmoller; I Cascorbi; M L Clapper; C Coutelle; A Daly; M Dell'Omo; V Dolzan; C M Dresler; A Fryer; A Haugen; D W Hein; A Hildesheim; A Hirvonen; L L Hsieh; M Ingelman-Sundberg; I Kalina; D Kang; M Kihara; C Kiyohara; P Kremers; P Lazarus; L Le Marchand; M C Lechner; E M van Lieshout; S London; J J Manni; C M Maugard; S Morita; V Nazar-Stewart; K Noda; Y Oda; F F Parl; R Pastorelli; I Persson; W H Peters; A Rannug; T Rebbeck; A Risch; L Roelandt; M Romkes; D Ryberg; J Salagovic; B Schoket; J Seidegard; P G Shields; E Sim; D Sinnet; R C Strange; I Stücker; H Sugimura; J To-Figueras; P Vineis; M C Yu; E Taioli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

7.  CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.

Authors:  Paolo Vineis; Fabrizio Veglia; Simone Benhamou; Dorota Butkiewicz; Ingolf Cascorbi; Margie L Clapper; Vita Dolzan; Aage Haugen; Ari Hirvonen; Magnus Ingelman-Sundberg; Masahiro Kihara; Chikako Kiyohara; Pierre Kremers; Loic Le Marchand; Susumu Ohshima; Roberta Pastorelli; Agneta Rannug; Marjorie Romkes; Bernadette Schoket; Peter Shields; Richard C Strange; Isabelle Stucker; Haruhiko Sugimura; Seymour Garte; Laura Gaspari; Emanuela Taioli
Journal:  Int J Cancer       Date:  2003-05-01       Impact factor: 7.396

8.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

9.  Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review.

Authors:  Paul Brennan; Sarah Lewis; Mia Hashibe; Douglas A Bell; Paolo Boffetta; Christine Bouchardy; Neil Caporaso; Chu Chen; Christiane Coutelle; Scott R Diehl; Richard B Hayes; Andrew F Olshan; Stephen M Schwartz; Erich M Sturgis; Qingyi Wei; Athanasios I Zavras; Simone Benhamou
Journal:  Am J Epidemiol       Date:  2004-01-01       Impact factor: 4.897

10.  Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer.

Authors:  Mia Hashibe; Paul Brennan; Richard C Strange; Rajani Bhisey; Ingolf Cascorbi; Philip Lazarus; Michael B Oude Ophuis; Simone Benhamou; William D Foulkes; Takahiko Katoh; Christiane Coutelle; Marjorie Romkes; Laura Gaspari; Emanuela Taioli; Paolo Boffetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-12       Impact factor: 4.254

View more
  15 in total

1.  Aerial pesticide application causes DNA damage in pilots from Sinaloa, Mexico.

Authors:  C Martínez-Valenzuela; S M Waliszewski; O Amador-Muñoz; E Meza; M E Calderón-Segura; E Zenteno; J Huichapan-Martínez; M Caba; R Félix-Gastélum; R Longoria-Espinoza
Journal:  Environ Sci Pollut Res Int       Date:  2016-11-05       Impact factor: 4.223

2.  Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.

Authors:  Marta Vilčková; Jana Jurečeková; Dušan Dobrota; Viera Habalová; Lucia Klimčáková; Iveta Waczulíková; Peter Slezák; Ján Kliment; Monika Kmeťová Sivoňová
Journal:  Med Oncol       Date:  2014-05-11       Impact factor: 3.064

3.  Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario.

Authors:  Arshad A Pandith; Mushtaq A Siddiqi
Journal:  Tumour Biol       Date:  2012-05-19

4.  Genotoxic effect of chronic exposure to DDT on lymphocytes, oral mucosa and breast cells of female rats.

Authors:  Alejandro Canales-Aguirre; Eduardo Padilla-Camberos; Ulises Gómez-Pinedo; Hugo Salado-Ponce; Alfredo Feria-Velasco; Ruth De Celis
Journal:  Int J Environ Res Public Health       Date:  2011-02-18       Impact factor: 3.390

5.  Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management.

Authors:  Francesca Megiorni; Antonio Pizzuti; Luigi Frati
Journal:  Patholog Res Int       Date:  2011-07-27

6.  The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study.

Authors:  Allan P Davis; Cynthia G Murphy; Michael C Rosenstein; Thomas C Wiegers; Carolyn J Mattingly
Journal:  BMC Med Genomics       Date:  2008-10-09       Impact factor: 3.063

7.  Somatic mutation patterns and compound response in cancers.

Authors:  Ningning He; Nayoung Kim; Sukjoon Yoon
Journal:  BMB Rep       Date:  2013-02       Impact factor: 4.778

Review 8.  MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.

Authors:  Anjan K Pradhan; Santanu Maji; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

9.  Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks.

Authors:  Allan Peter Davis; Cynthia G Murphy; Cynthia A Saraceni-Richards; Michael C Rosenstein; Thomas C Wiegers; Carolyn J Mattingly
Journal:  Nucleic Acids Res       Date:  2008-09-09       Impact factor: 16.971

10.  Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor development.

Authors:  Joe M Angel; Erika L Abel; Penny K Riggs; S Alex McClellan; John DiGiovanni
Journal:  G3 (Bethesda)       Date:  2014-04-03       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.